Ophthalmology
Volume 114, Issue 6 , Pages 1037-1038 , June 2007

The Role of Pharmaceutical Companies in Sponsored Research

References 

  1. Fortune 500, 2006: ranking of America’s largest corporations. Fortune 2006;153(7):F60. Available at: http://money.cnn.com/magazines/fortune/fortune500/industries/Pharmaceuticals/1.html. Accessed February 28, 2007.
  2. Levobunolol Study Group. Levobunolol: a four-year study of efficacy and safety in glaucoma treatment. Ophthalmology. 1989;96:642–645
  3. Netland PA, Landry T, Sullivan EK, et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2001;132:472–484
  4. Strahlman E, Tipping R, Vogel R International Dorzolamide Study Group. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. Arch Ophthalmol. 1995;113:1009–1016
  5. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953
  6. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–713
  7. Sorbinil Retinopathy Trial Research Group. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Arch Ophthalmol. 1990;108:1234–1244
  8. Novack GD. ARVO commercial relationships policy: financial disclosure in ARVO presentations and publications. Invest Ophthalmol Vis Sci. 1999;40:2765–2766
  9. Statement of ethical values. Adopted by the Regents of the University of California, May, 2005. Available at: http://www.universityofcalifornia.edu/compliance/ethics/ethicalvalues.html. Accessed February 15, 2007.
  10. Three-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. 1993;115:82–92
  11. Herson J. Data monitoring boards in the pharmaceutical industry. Stat Med. 1993;12:555–561

PII: S0161-6420(07)00216-3

doi: 10.1016/j.ophtha.2007.02.027

Ophthalmology
Volume 114, Issue 6 , Pages 1037-1038 , June 2007

Article Tools